对于多巴胺激动剂在治疗益生菌瘤的经验
Nadiya Ye Barabash1, Tetiana M Tykhonova1
1V. N. Karazin Kharkiv National University, Kharkiv, Ukraine.
Acta medica Lituanica
|September 21, 2023
概括
卡伯戈林有效地治疗导致高血的垂体瘤,减少瘤大小并恢复视力. 然而,对多巴胺激动剂的耐药性仍然是管理这种疾病的挑战.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 催性腺素过高,通常是由垂体瘤引起的,需要有效的治疗策略.
- 多巴胺激动剂是治疗高血糖性血症的主要药物治疗方法.
研究的目的:
- 为了评估卡伯戈林在治疗导致高血的垂体瘤中的疗效.
- 探索与多巴胺激动剂耐药性相关的挑战,以管理高血糖性血症.
主要方法:
- 对患有下垂体瘤和高血的患者的案例研究分析.
- 对临床结果的审查,包括瘤大小,益生素水平和视觉功能.
主要成果:
- 卡伯戈林在减少垂体腺瘤大小 (从宏观到微观) 和解决综合征方面表现出显著的疗效.
- 观察到成功实现和维持目标益生素水平.
- 一例二次多巴胺耐药症突出显示了治疗优化方面的挑战,可能与剂量不足有关.
结论:
- 卡伯戈林是一种高度有效的治疗方法,既用于微腺瘤,也用于导致超益生菌血症的大型垂体瘤.
- 多巴胺激动剂耐药性,特别是二次耐药性,是一个复杂的临床问题,需要进一步调查和优化治疗策略.
相关概念视频
Parkinson's Disease: Treatment
292
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
292
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
367
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
367
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
320
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
320
Direct-Acting Cholinergic Agonists: Therapeutic Uses
784
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
784
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


